Clinical trials recruiting for Breast Cancer Female
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Massachusetts | 4 |
| California | 3 |
| Pennsylvania | 3 |
| Texas | 3 |
| Florida | 2 |
| New York | 2 |
| Arizona | 1 |
| Connecticut | 1 |
| Illinois | 1 |
| Kansas | 1 |
| Maryland | 1 |
| Michigan | 1 |
Top cities
Self-screener
Recruiting trials
- 18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer
- 18F-FDG PET/CT Imaging for Breast Cancer
- A Prospective Evaluation of the Peri-operative Hypoxia in Breast Cancer
- A Study to Identify Breast Cancer (IDBC)
- ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)
- Anatomical Landmarks for Chest Wall Perforators Used for Partial Breast Reconstruction
- Assessment of Oncological Safety, Quality of Life, and Environmental Impact of the Green Breast Surgery Protocol
- Biennial CEM in Women With a Personal History of Breast Cancer
- Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors
- Body Image and Physical Activity of Women with Breast Cancer
- Breast Cancer Resiliency Through Exercise Program (B-REP)
- Comparing Patient Reported Outcomes and Clinical Outcomes Based on Different Scar Placement in Patients Undergoing Standard Breast Conserving Surgery for Breast Cancer: The PROM-S Study.
- Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein)
- Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
- Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
- DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Dermatitis During Adjuvant Irradiation for BREAst Cancer:
- ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer
- EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
- Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
- Effects of Negative Pressure Wound Bandaging After Mastectomy
- Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction
- Evaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast Cancer
- Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore
- External Vacuum Expansion: Evaluation in Breast Reconstructive Surgery Evaluation in Breast Reconstructive Surgery
- First-in-human, Study of MATTISSE® Tissue Engineering Chamber in Adult Female Patients Undergoing Breast Reconstruction After Mastectomy for Cancer
- GammaPod Registry and Quality of Life Nomogram
- Genitourinary Syndrome of Menopause in Breast Cancer
- Guided Digital Self-Hypnosis Solution for Managing Hot Flashes in Patients Undergoing Adjuvant Hormone Therapy
- High Intensity Focused Ultrasound Treatment of Breast Tumors. BRIFU Study
- Lactobacillus Vaginalis Capsules for Treatment of Vulvovaginal Atrophy in Young Breast Cancer Patients
- Long-Term Multidisciplinary Physiotherapy for Breast Cancer Survivors: A Randomized Controlled Trial
- Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
- Metabolic Flexibility and Autonomic Control After Muscle Power vs Metabolic Power Training in Postmenopausal Oncological Women: the POWER Health Study
- Microbiome and Association With Implant Infections
- Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging
- Multiple Risk Factor Intervention Trial in Breast Cancer Survivors
- One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer
- PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women
- Pelvic Health Rehabilitation After Breast and Gynecologic Cancer
- Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
- Pre-Operative Window of ET to Inform RT Decisions (POWER II)
- Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
- Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer
- Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT
- Study of Lipid Mediators in Chronic Postoperative Pain - LICP
- Supporting Health Including Endocrine Treatment for Long Duration
- THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
- Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
- Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
- TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
- The Benefits of Continued Use of Ovarian Function Suppression After 5 Years
- The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project
- The MASTER Study (MAmmary Cancer STatin ER Positive Study)
- Time Restricted Eating During Chemotherapy for Breast Cancer
- To Assess the Contribution of Sophrology Assisted by an Ambulatory Device on the Anxiety of Patients Undergoing Chemotherapy for the Treatment of Localized Breast Cancer
- Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
- UCF MammoChat: Image Repository
- Ultra-hypofractionated for Whole Breast Irradiation (WBI) Compared to Partial Breast Irradiation (PBI)
- Use of GnRHa During Chemotherapy for Fertility Protection
- Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Related conditions
Trials recruiting for Breast Cancer Female often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Breast Cancer Female trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.